Hepatocellular carcinoma with cirrhosis: Are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus?

American Journal of Roentgenology

Volumn 193, Issue 4, 2009, Pages 948-954

  Giorgio, Antonio ^a   Di Sarno, Antonella ^a   De Stefano, Giorgio ^a   Farella, Nunzia ^a   Scognamiglio, Umberto ^a   De Stefano, Manuela ^a   Giorgio, Valentina ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Portal vein; Portal venous tumor thrombus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER INVASION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; ELECTRODE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NECROSIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECANALIZATION; SAFETY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR THROMBUS; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; NEOPLASM INVASIVENESS; PORTAL VEIN; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 70349694276     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.2087     Document Type: Article

References (39)

1. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001; 28:441-449
2. Fattovich G, Stroffolini T, Zagni I, Donato E. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127[suppl]: S35-S50 (Pubitemid 39423368)
3. Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 2006; 21:7561-7567 (Pubitemid 46040565)
4. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspective of public health problem to tumor biology. J Gastroenterol 2009; 44[suppl 19]:96-101
5. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14:4300-4308
6. Takizawa D, Kakizaki S, Sohara N, et al. Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci 2007; 52:3290-3295 (Pubitemid 47512562)
7. Abdel-Wahab M, El-Ghawalby N, Mostafa M, et al. Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center. Hepatogastroenterology 2007; 54:157-162 (Pubitemid 46511667)
8. Elefsiniotis IS, Diamantis ID, Dourakis SP, Kafiri G, Pantazis K, Mavrogiannis C. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma: relationship with portal vein thrombosis. Eur J Gastroenterol Hepatol 2003; 15:721-726 (Pubitemid 36870648)
9. Fujii T, Takayasu K, Muramatsu Y, et al. Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis. Jpn J Clin Oncol 1993; 23:105-109
10. Rabe C, Pilz T, Klostermann C, et al. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001; 7:208-215 (Pubitemid 32377472)
11. Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated non surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29:62-67 (Pubitemid 29023987)
12. Villa E, Moles A, Ferretti I, et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology 2000; 32:233-238 (Pubitemid 30614655)
13. Rossi S, Garbagnati F, Luciani R, et al. Percutaneous radiofrequency thermal ablation of non resectable hepatocellular carcinoma after occlusion of tumor blood therapy. Radiology 2000; 217:119-126 (Pubitemid 33097587)
14. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000; 214:761-768 (Pubitemid 30115377)
15. Seror O, N'Kontchon G, Ibralium M, et al. Large (> or = 5 cm) HCCs: multipolar RF ablation with three internally coded bipolar electrodes: initial experience in 26 patients. Radiology 2008; 248:288-296
16. Giorgio A, Tarantino L, de Stefano G, et al. Ultrasound- guided percutaneous ethanol injection under general anaesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients. Eur J Ultrasound 2000; 12:145-154
17. Neeman Z, Libutti SK, Patti JW, Wood BJ. Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. Clin Imaging 2003; 27:417-420 (Pubitemid 37329772)
18. Poggi G, Gatti C, Teragni C, Delmonte A, Bernardo G. Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis. Anticancer Res 2004; 24:2419-2421 (Pubitemid 39166326)
19. Giorgio A, Ferraioli G, Tarantino L, et al. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR 2004; 183:1319-1326 (Pubitemid 44210595)
20. Gaiani S, Celli N, Piscaglia F, et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004; 41:421-426 (Pubitemid 39158751)
21. Giorgio A, de Stefano G, Coppola C, et al. Contrast- enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging. Anticancer Res 2007; 27:4263-4270
22. Pompili M, Riccardi L, Semeraro S, et al. Contrast- enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver. Dig Liver Dis 2008; 40:206-215 (Pubitemid 351181794)
23. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236
24. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS): update 2008. Ultraschall Med 2008; 29:28-44 (Pubitemid 351294171)
25. Giorgio A, Tarantino L, de Stefano G, et al. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. AJR 2003; 181:479-484 (Pubitemid 36909494)
26. Obi S, Yoshida H, Toure R, et al. Combination therapy of intra-arterial 5 fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006; 106:1990-1997 (Pubitemid 43673215)
27. Chen XP, Qiu FZ, Wu ZD, et al. Effects of location and extension of portal vein tumor thrombus on long term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 2006; 13:940-946
28. Konishi M, Ryu M, Kinoshita T, Inoue K. Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 2001; 48:1421-1424 (Pubitemid 33010438)
29. Pawlik TM, Poon RT, Abdalla EK, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 2005; 137:403-410
30. Ikai I, Yamamoto Y, Yamamoto N, et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am 2003; 12:65-75 (Pubitemid 36204980)
31. Le Treut YP, Hardwigsen J, Ananian P, et al. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature: a European case-control series. J Gastrointest Surg 2006; 10:855-862 (Pubitemid 43850379)
32. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusion of the Barcelona 2000 EASL conference. J Hepatol 2001; 35:421-430
33. Livraghi T, Grigioni W, Mazziotti A, Sangalli G, Vettori C. Percutaneous alcohol injection of portal thrombosis in hepatocellular carcinoma: a new possible treatment. Tumori 1990; 76:394-397
34. Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound 2001; 13:159-166 (Pubitemid 32458011)
35. Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009; 249:20-25
36. Giorgio A, Tarantino L, de Stefano G, et al. Complications after interventional sonography of focal liver lesions: a 22-year single-center experience. J Ultrasound Med 2003; 22:193-205 (Pubitemid 36143094)
37. Giorgio A, Tarantino L, de Stefano G, Coppola C, Ferraioli G. Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: a 3 year experience with 336 patients at a single center. AJR 2005; 184:207-211 (Pubitemid 40040930)
38. Delis S, Bramis I, Triantopoulou C, Madariaga J, Dervenis C. The imprint of radiofrequency in the management of hepatocellular carcinoma. HPB (Oxford) 2006; 8:255-263 (Pubitemid 44044242)
39. Livraghi T, Goldberg SN, Monti F, et al. Saline enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1977; 202:205-210